Style | Citing Format |
---|---|
MLA | Gholamrezaei A, Nemati K, Emami MH. "Which End Point Is More Comprehensive in Reflecting Changes in Irritable Bowel Syndrome Treatment Trials?." American Journal of Gastroenterology, vol. 104, no. 11, 2009, pp. 2859-. |
APA | Gholamrezaei A, Nemati K, Emami MH (2009). Which End Point Is More Comprehensive in Reflecting Changes in Irritable Bowel Syndrome Treatment Trials?. American Journal of Gastroenterology, 104(11), 2859-. |
Chicago | Gholamrezaei A, Nemati K, Emami MH. "Which End Point Is More Comprehensive in Reflecting Changes in Irritable Bowel Syndrome Treatment Trials?." American Journal of Gastroenterology 104, no. 11 (2009): 2859-. |
Harvard | Gholamrezaei A, Nemati K, Emami MH (2009) 'Which End Point Is More Comprehensive in Reflecting Changes in Irritable Bowel Syndrome Treatment Trials?', American Journal of Gastroenterology, 104(11), pp. 2859-. |
Vancouver | Gholamrezaei A, Nemati K, Emami MH. Which End Point Is More Comprehensive in Reflecting Changes in Irritable Bowel Syndrome Treatment Trials?. American Journal of Gastroenterology. 2009;104(11):2859-. |
BibTex | @article{ author = {Gholamrezaei A and Nemati K and Emami MH}, title = {Which End Point Is More Comprehensive in Reflecting Changes in Irritable Bowel Syndrome Treatment Trials?}, journal = {American Journal of Gastroenterology}, volume = {104}, number = {11}, pages = {2859-}, year = {2009} } |
RIS | TY - JOUR AU - Gholamrezaei A AU - Nemati K AU - Emami MH TI - Which End Point Is More Comprehensive in Reflecting Changes in Irritable Bowel Syndrome Treatment Trials? JO - American Journal of Gastroenterology VL - 104 IS - 11 SP - 2859 EP - PY - 2009 ER - |